Armand Keating
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Medicine and Surgery, Medical BiophysicsGoogle:
"Armand Keating"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Simon J. Bubnic | grad student | 2003 | University of Toronto |
| Sonia Montanari | grad student | 2014 | University of Toronto |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Saber W, Steinert P, Zhang MJ, et al. (2021) A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies. Transplantation and Cellular Therapy |
| Weinhäuser I, Pereira-Martins DA, Ortiz C, et al. (2020) Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia. Cancers. 12 |
| Thomé CH, Ferreira GA, Pereira-Martins DA, et al. (2020) NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports. 10: 10315 |
| Tang C, Espin-Garcia O, Prica A, et al. (2020) Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphoma. Leukemia & Lymphoma. 1-8 |
| Assouline S, Li S, Gisselbrecht C, et al. (2020) The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL. Blood Advances. 4: 2011-2017 |
| Chapman L, Abdi J, Galvez-Peisl S, et al. (2020) Immunophenotypic and functional characterisation of Mesodermal Killer (MK) cells: a novel cell type and potential cellular therapy for cancer Cytotherapy. 22 |
| Krieger E, Sivagnanaling UU, Webb C, et al. (2020) Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival Biology of Blood and Marrow Transplantation. 26 |
| Krieger E, Sabo R, Moezzi S, et al. (2019) Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
| Williams BA, Law A, Hunyadkurti J, et al. (2019) Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats. Journal of Clinical Medicine. 8 |
| Lucena-Araujo AR, Coelho-Silva JL, Pereira-Martins DA, et al. (2019) Combining gene mutation with gene expression analysis improves outcomes prediction in acute promyelocytic leukemia. Blood |